RizzaS, FilomeniG. Re: “Regulation of S-Nitrosylation in Aging and Senescence” by Larrick and Mendelsohn (Rejuvenation Res 2019;22:171–174). Rejuvenation Res, 2019; 22:359–361.
2.
LarrickJW, MendelsohnAR. Regulation of S-nitrosylation in aging and senescence. Rejuvenation Res, 2019; 22:171–174.
3.
BarnettSD, BuxtonILO. The role of S-nitrosoglutathione reductase (GSNOR) in human disease and therapy. Crit Rev Biochem Mol Biol, 2017; 52:340–54.
4.
RizzaS, FilomeniG. Denitrosylate and live longer: how ADH5/GSNOR links mitophagy to aging. Autophagy, 2018; 14:1285–1287.
5.
HatzistergosKE, PaulinoEC, DulceRA, et al.S-nitrosoglutathione reductase deficiency enhances the proliferative expansion of adult heart progenitors and myocytes post myocardial infarction. J Am Heart Assoc, 2015; 4:pii: e001974
6.
MoonY, CaoY, ZhuJ, et al.GSNOR deficiency enhances in situ skeletal muscle strength, fatigue resistance, and RyR1 S-nitrosylation without impacting mitochondrial content and activity. Antioxid Redox Signal, 2017; 26:165–181.
7.
ZhangY, WuK, SuW, et al.Increased GSNOR expression during aging impairs cognitive function and decreases S-nitrosylation of CaMKIIα. J Neurosci, 2017; 37:9741–9758.
8.
RizzaS, CardaciS, MontagnaC, et al.S-nitrosylation drives cell senescence and aging in mammals by controlling mitochondrial dynamics and mitophagy. Proc Natl Acad Sci USA, 2018; 115:E3388–E3397.
